Jun 16, 2020
Intermolecular Announces Breakthrough Four-Element ALD Chalcogenide-based OTS for 3D Memory Arrays
Jun 09, 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
May 28, 2020
Merck KGaA, Darmstadt, Germany, and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living with MS
May 27, 2020
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
May 11, 2020
MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
Mar 25, 2020
TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations
Mar 25, 2020
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Mar 18, 2020
Technological Advancements to Drive Significant Growth in the Life Science Reagents Market from 2019 to 2027, States TMR
Feb 06, 2020
EMD Serono Receives Positive Recommendation for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis from the Institut national d'excellence en santé et en services sociaux (INESSS)
Jan 14, 2020
Biologics Safety Testing Market Size Hit US$ 4.8 Bn by 2026
Jan 07, 2020
Predicine and Merck KGaA, Darmstadt, Germany to Present Data at AACR - Advances in Liquid Biopsy Conference 2020
Dec 19, 2019
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
Dec 18, 2019
Merck Foundation CEO, Rasha Kelej Named Among Top 100 Most Influential Africans
Dec 10, 2019
EMD Serono and the pan-Canadian Pharmaceutical Alliance Complete Negotiations for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis
Dec 04, 2019
Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China
Nov 26, 2019
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
Nov 20, 2019
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
Nov 12, 2019
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
Nov 05, 2019
Medisafe Announces Strong Results from Digital Medication Management Programs
Oct 24, 2019
TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry